Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Lack of association between the UDP-glucuronosyltransferase 1A1 (UGT1A1) gene polymorphism and the risk of benign prostatic hyperplasia in Caucasian men.

Molecular biology reports - 1 Dec 2013

Karatzas Anastasios, Tzortzis Vassilios, Giannatou Eirini, Gravas Stavros, Zachos Ioannis, Oeconomou Athanassios, Melekos Michael, Tsezou Aspasia

Abstract excerpt

Glucuronidation, mediated by the UDP-glucuronosyltransferase 1A1 (UGT1A1) enzyme, is an important metabolic process during which steroids are converted to more easily excreted compounds in steroid target tissues, such as the prostate. The aim of our study was to investigate the possible correlation between UGT1A1 promoter gene polymorphism and benign prostatic hyperplasia. 421 blood samples were obtained from 138...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Case-Control Studies
Share to Demography

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Association Studies

Share to Glucuronosyltransferase

Share to Polymorphism, Genetic

Share to Prostatic Hyperplasia

Share to Risk Factors

Share to White People

Source

Identifiers

PMID: 24057187
DOI: 10.1007/s11033-013-2781-2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Lack of association between the UDP-glucuronosyltransferase 1A1 (UGT1A1) gene polymorphism and the risk of benign prostatic hyperplasia in Caucasian men.PMID 24057187Read ↗

CYP17 gene promoter allelic variant is not associated with prostate cancer.Semantic proximity Read ↗

Genetic association between PSA-158G/A polymorphism and the susceptibility of benign prostatic hyperplasia: a meta-analysis.Semantic proximity Read ↗

CYP3A4 promoter variant is associated with prostate cancer risk in men with benign prostate hyperplasia.Semantic proximity Read ↗

Lack of association between CYP17 Mspa1 polymorphism and prostate cancer risk: a meta-analysis of 14494 cases and 15971 controls.Semantic proximity Read ↗

Increased risk of prostate cancer and benign prostatic hyperplasia associated with a CYP17 gene polymorphism with a gene dosage effect.Semantic proximity Read ↗

Prostate-specific antigen and 17-hydroxylase polymorphic genotypes in patients with prostate cancer and benign prostatic hyperplasia.Semantic proximity Read ↗

Cyp17 genetic polymorphism in prostate cancer and benign prostatic hyperplasia.Semantic proximity Read ↗

Genetic polymorphism and pathogenesis of benign prostatic hyperplasia.Semantic proximity Read ↗

Lack of association of CYP1A1 polymorphism with prostate cancer susceptibility of Tunisian men.Semantic proximity Read ↗

No association of the 5' promoter region polymorphism of CYP17 gene with prostate cancer risk.Semantic proximity Read ↗

Androgen receptor CAG polymorphism and the risk of benign prostatic hyperplasia in a Brazilian population.Semantic proximity Read ↗

Glutathione S-transferase (GST) gene variants and risk of benign prostatic hyperplasia: a report in a North Indian population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.